Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Targeted therapies for rare lung diseases. About Us Avalyn is a clinical-stage biotech company developing inhaled therapies to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.
Technologies
Tech DNA
GCP
DevOps
GCP
Stack modernity
64/100
How modern this stack is, based on technology relevance, AI adoption and the share of legacy tools.
Industry adoption
GCP
18%
Share of companies in the same industry that use each technology.
Stack changes
GCP
Aug 2026
Technologies recently added to or removed from this company's stack - a signal of tech migrations and new initiatives.
Growth
Hiring Momentum
56/100
Growing
Open positions
0
1 opened / 0 closed in 30 days
ATS activity
Every ~18 hours
08/31/2026
Hiring Dynamics
0%
Activity Timeline
Added GCP to stack
Aug 2026